(SBS) Companhia de Saneamento - Overview
Exchange: NYSE •
Country: Brazil •
Currency: USD •
Type: Common Stock •
ISIN: US20441A1025
Stock:
Total Rating 50
Risk 41
Buy Signal 0.07
| Risk 5d forecast | |
|---|---|
| Volatility | 28.1% |
| Relative Tail Risk | -1.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.12 |
| Alpha | 81.86 |
| Character TTM | |
|---|---|
| Beta | 0.415 |
| Beta Downside | 0.042 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.79% |
| CAGR/Max DD | 2.11 |
EPS (Earnings per Share)
Revenue
Description: SBS Companhia de Saneamento
Companhia de Saneamento Básico do Estado de São Paulo - SABESP provides basic and environmental sanitation services in the São Paulo State, Brazil. The company supplies treated water and sewage services on a wholesale basis. As of December 31, 2024, it provided water services through 9.5 million water connections; and sewage services through 8.2 million sewage connections in the 375 municipalities of the São Paulo State. Companhia de Saneamento Básico do Estado de São Paulo - SABESP was founded in 1954 and is headquartered in São Paulo, Brazil.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 8.03b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -22.60 > 1.0 |
| NWC/Revenue: -4.80% < 20% (prev 0.51%; Δ -5.31% < -1%) |
| CFO/TA 0.11 > 3% & CFO 10.12b > Net Income 8.03b |
| Net Debt (29.96b) to EBITDA (14.69b): 2.04 < 3 |
| Current Ratio: 0.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (683.1m) vs 12m ago -0.08% < -2% |
| Gross Margin: 35.31% > 18% (prev 0.55%; Δ 3476 % > 0.5%) |
| Asset Turnover: 74.75% > 50% (prev 249.0%; Δ -174.2% > 0%) |
| Interest Coverage Ratio: 13.49 > 6 (EBITDA TTM 14.69b / Interest Expense TTM 958.4m) |
Altman Z'' 2.90
| A: -0.02 (Total Current Assets 12.56b - Total Current Liabilities 14.53b) / Total Assets 95.99b |
| B: 0.19 (Retained Earnings 18.25b / Total Assets 95.99b) |
| C: 0.23 (EBIT TTM 12.93b / Avg Total Assets 55.14b) |
| D: 0.80 (Book Value of Equity 42.71b / Total Liabilities 53.28b) |
| Altman-Z'' Score: 2.90 = A |
Beneish M 0.95
| DSRI: 5.14 (Receivables 4.48b/753.3m, Revenue 41.21b/35.57b) |
| GMI: 1.55 (GM 35.31% / 54.67%) |
| AQI: 0.97 (AQ_t 0.86 / AQ_t-1 0.89) |
| SGI: 1.16 (Revenue 41.21b / 35.57b) |
| TATA: -0.02 (NI 8.03b - CFO 10.12b) / TA 95.99b) |
| Beneish M-Score: 0.95 (Cap -4..+1) = D |
What is the price of SBS shares?
As of February 28, 2026, the stock is trading at USD 30.01 with a total of 863,479 shares traded.
Over the past week, the price has changed by +1.18%, over one month by +10.74%, over three months by +16.00% and over the past year by +92.96%.
Over the past week, the price has changed by +1.18%, over one month by +10.74%, over three months by +16.00% and over the past year by +92.96%.
Is SBS a buy, sell or hold?
Companhia de Saneamento has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy SBS.
- StrongBuy: 3
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SBS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.9 | 2.9% |
| Analysts Target Price | 30.9 | 2.9% |
SBS Fundamental Data Overview February 28, 2026
Market Cap BRL = 109.02b (21.21b USD * 5.14 USD.BRL)
P/E Trailing = 15.145
P/E Forward = 11.5207
P/S = 0.612
P/B = 2.1543
P/EG = 2.55
Revenue TTM = 41.21b BRL
EBIT TTM = 12.93b BRL
EBITDA TTM = 14.69b BRL
Long Term Debt = 28.92b BRL (from longTermDebt, last quarter)
Short Term Debt = 5.78b BRL (from shortTermDebt, last quarter)
Debt = 34.93b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.96b BRL (from netDebt column, last quarter)
Enterprise Value = 139.25b BRL (109.02b + Debt 34.93b - CCE 4.69b)
Interest Coverage Ratio = 13.49 (Ebit TTM 12.93b / Interest Expense TTM 958.4m)
EV/FCF = 13.81x (Enterprise Value 139.25b / FCF TTM 10.08b)
FCF Yield = 7.24% (FCF TTM 10.08b / Enterprise Value 139.25b)
FCF Margin = 24.46% (FCF TTM 10.08b / Revenue TTM 41.21b)
Net Margin = 19.50% (Net Income TTM 8.03b / Revenue TTM 41.21b)
Gross Margin = 35.31% ((Revenue TTM 41.21b - Cost of Revenue TTM 26.66b) / Revenue TTM)
Gross Margin QoQ = 31.77% (prev 41.82%)
Tobins Q-Ratio = 1.45 (Enterprise Value 139.25b / Total Assets 95.99b)
Interest Expense / Debt = 0.46% (Interest Expense 161.9m / Debt 34.93b)
Taxrate = 33.40% (1.08b / 3.24b)
NOPAT = 8.61b (EBIT 12.93b * (1 - 33.40%))
Current Ratio = 0.86 (Total Current Assets 12.56b / Total Current Liabilities 14.53b)
Debt / Equity = 0.82 (Debt 34.93b / totalStockholderEquity, last quarter 42.71b)
Debt / EBITDA = 2.04 (Net Debt 29.96b / EBITDA 14.69b)
Debt / FCF = 2.97 (Net Debt 29.96b / FCF TTM 10.08b)
Total Stockholder Equity = 39.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.57% (Net Income 8.03b / Total Assets 95.99b)
RoE = 20.28% (Net Income TTM 8.03b / Total Stockholder Equity 39.62b)
RoCE = 18.86% (EBIT 12.93b / Capital Employed (Equity 39.62b + L.T.Debt 28.92b))
RoIC = 12.29% (NOPAT 8.61b / Invested Capital 70.07b)
WACC = 5.72% (E(109.02b)/V(143.94b) * Re(7.45%) + D(34.93b)/V(143.94b) * Rd(0.46%) * (1-Tc(0.33)))
Discount Rate = 7.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.03%
[DCF] Terminal Value 88.43% ; FCFF base≈7.94b ; Y1≈9.80b ; Y5≈16.68b
[DCF] Fair Price = 651.0 (EV 485.78b - Net Debt 29.96b = Equity 455.83b / Shares 700.2m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -56.47 | EPS CAGR: -50.64% | SUE: -1.01 | # QB: 0
Revenue Correlation: 79.64 | Revenue CAGR: 18.02% | SUE: 0.87 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.43 | Chg7d=+0.026 | Chg30d=+0.026 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.90 | Chg7d=+0.043 | Chg30d=+0.101 | Revisions Net=+2 | Growth EPS=+4.5% | Growth Revenue=+11.3%
P/E Trailing = 15.145
P/E Forward = 11.5207
P/S = 0.612
P/B = 2.1543
P/EG = 2.55
Revenue TTM = 41.21b BRL
EBIT TTM = 12.93b BRL
EBITDA TTM = 14.69b BRL
Long Term Debt = 28.92b BRL (from longTermDebt, last quarter)
Short Term Debt = 5.78b BRL (from shortTermDebt, last quarter)
Debt = 34.93b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.96b BRL (from netDebt column, last quarter)
Enterprise Value = 139.25b BRL (109.02b + Debt 34.93b - CCE 4.69b)
Interest Coverage Ratio = 13.49 (Ebit TTM 12.93b / Interest Expense TTM 958.4m)
EV/FCF = 13.81x (Enterprise Value 139.25b / FCF TTM 10.08b)
FCF Yield = 7.24% (FCF TTM 10.08b / Enterprise Value 139.25b)
FCF Margin = 24.46% (FCF TTM 10.08b / Revenue TTM 41.21b)
Net Margin = 19.50% (Net Income TTM 8.03b / Revenue TTM 41.21b)
Gross Margin = 35.31% ((Revenue TTM 41.21b - Cost of Revenue TTM 26.66b) / Revenue TTM)
Gross Margin QoQ = 31.77% (prev 41.82%)
Tobins Q-Ratio = 1.45 (Enterprise Value 139.25b / Total Assets 95.99b)
Interest Expense / Debt = 0.46% (Interest Expense 161.9m / Debt 34.93b)
Taxrate = 33.40% (1.08b / 3.24b)
NOPAT = 8.61b (EBIT 12.93b * (1 - 33.40%))
Current Ratio = 0.86 (Total Current Assets 12.56b / Total Current Liabilities 14.53b)
Debt / Equity = 0.82 (Debt 34.93b / totalStockholderEquity, last quarter 42.71b)
Debt / EBITDA = 2.04 (Net Debt 29.96b / EBITDA 14.69b)
Debt / FCF = 2.97 (Net Debt 29.96b / FCF TTM 10.08b)
Total Stockholder Equity = 39.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.57% (Net Income 8.03b / Total Assets 95.99b)
RoE = 20.28% (Net Income TTM 8.03b / Total Stockholder Equity 39.62b)
RoCE = 18.86% (EBIT 12.93b / Capital Employed (Equity 39.62b + L.T.Debt 28.92b))
RoIC = 12.29% (NOPAT 8.61b / Invested Capital 70.07b)
WACC = 5.72% (E(109.02b)/V(143.94b) * Re(7.45%) + D(34.93b)/V(143.94b) * Rd(0.46%) * (1-Tc(0.33)))
Discount Rate = 7.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.03%
[DCF] Terminal Value 88.43% ; FCFF base≈7.94b ; Y1≈9.80b ; Y5≈16.68b
[DCF] Fair Price = 651.0 (EV 485.78b - Net Debt 29.96b = Equity 455.83b / Shares 700.2m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -56.47 | EPS CAGR: -50.64% | SUE: -1.01 | # QB: 0
Revenue Correlation: 79.64 | Revenue CAGR: 18.02% | SUE: 0.87 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.43 | Chg7d=+0.026 | Chg30d=+0.026 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.90 | Chg7d=+0.043 | Chg30d=+0.101 | Revisions Net=+2 | Growth EPS=+4.5% | Growth Revenue=+11.3%